Navigating the global regulatory landscape is one of the biggest challenges in clinical research. Each region has unique requirements, submission timelines, and approval processes. GCI’s Regulatory Intelligence service provides sponsors with up-to-date, actionable insights into Australian and international regulatory frameworks.
Service features
By offering tailored strategies, GCI helps accelerate approvals, minimize risks, and ensure 100% compliance with regional and global standards.
Global & Local Monitoring
Continuous analysis of evolving regulations from TGA (Australia), FDA (US), EMA (Europe), and other major authorities.
Submission Excellence
Comprehensive preparation and submission of Clinical Trial Applications (CTAs), ethics applications, IND dossiers, and more.
Risk Analysis & Mitigation
Identifying potential regulatory barriers early and developing contingency strategies.
Audit Readiness
Preparing sponsors and sites for inspections by ensuring compliance at every stage.
Problems we solve
- Confusion over regional submission pathways.
- Avoidable delays caused by incomplete or non-compliant documentation.
- Risks associated with regulatory findings during audits.
Popular questions
Why is regulatory intelligence important for new trials in Australia?
Australia has specific regulatory pathways and ethics requirements. Regulatory intelligence helps sponsors understand these requirements clearly, reducing delays and compliance risks.
Does GCI only handle Australian regulations?
No, GCI monitors and manages both Australian and global regulations, ensuring seamless multi-country trial approvals.
Can GCI help with both ethics and regulatory submissions?
Yes, GCI prepares and manages both ethics applications and regulatory submissions, ensuring consistency across all documentation.
